5. Getting It Right from the Start—Controversies in Dosing of Antimicrobials
Wednesday, October 26, 2016: 1:30 PM-3:30 PM
Room: 271-273
Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss options for optimizing the dosing of vancomycin and daptomycin
  • describe appropriate dosing of antibiotics in obese patients
  • discuss appropriate dosing of antibiotics in the critical care setting

Target Audience: Academicians, Clinicians, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Members-in-training, Pharmacists

Tracks: Adult ID, Pediatric ID

Moderators:  David R. Andes, M.D., FIDSA, University of Wisconsin School of Medicine and Public Health and Deborah Goff, PharmD, Ohio State University

1:30 PM
Vancomycin Concentration Monitoring
Keith Rodvold, Pharm D, FIDSA

1:55 PM
2:00 PM
Daptomycin Dose Level
Sujata Bhavnani, Pharm.D., M.S.
2:25 PM
2:30 PM
Under Dosing of Antibiotics in the ICU
Jason Roberts, BPharm(Hons), PhD

2:55 PM
3:00 PM
Under and Overdosing in Obesity
Amit Pai, PharmD, BCPS
3:25 PM

CME Credits: Maximum of 2 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 2 knowledge-based contact hours 0.2 of pharmacy CE

ACPE Number: 0221-9999-16-203-L01-P


D. R. Andes, Astellas, Roche, Melinta, Actelion, Theravance, Paratek, Zavante, Scynexis: Grant Investigator , Grant recipient
Actelion, Melinta, Scynexis, Roche, Theravance, Meiji: Consultant , Consulting fee

D. Goff, Allergan: Scientific Advisor , Consulting fee
Cepheid: Scientific Advisor , Consulting fee
Merck: Speaker's Bureau , Speaker honorarium
Astellas: Speaker's Bureau , Speaker honorarium
Medicine Company: Scientific Advisor , Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.